• New England Hemolytics will be attending Biotech Showcase in San Francisco January 12th - 15th, 2025. Any qualified investor interested in meeting with our team and learning about our Seed stage company can contact us through the ParteringONE website, or reach out directly to the founder at john.nobile@newenglandhemolytics.com
• 
• October 17, 2024
  New England Hemolytics has been invited to present a poster describing their breakthrough technology at the BARDA Innovation Symposium 2024.  This event will showcase early-stage health security innovations in order to facilitate collaborations for the innovators, funders, and industry partners.    
  Event details: BARDA Innovation Symposium  Wednesday, November 6, 2024, 9 am – 5 pm, 400 7th St SW, Washington, DC 20024 
  https://drive.hhs.gov/innovation2024.html
• October 16, 2024New England Hemolytics will be attending Biofuture in NYC, which runs October 28-30.
  John Nobile, Founder and CEO, will be presenting on October 30, 10AM. Onsite meetings may be scheduled by attendees through hellopartnering.com or by contacting us directly at info@newenglandhemolytics.com
• September 14, 2024
  New England Hemolytics has been awarded a National Science Foundation SBIR Phase 1 research grant to advance our novel whole blood extraction technology.
  Read more
• New England Hemolytics Inc. will be attending Biotech Showcase January  8-10, 2024
  Hilton San Francisco - Union Square
  333 O'Farrell Street, Ballroom Level
  San Francisco, CA 94102
  Meeting slots available for in-person or virtual partnering, or learn about our company & revolutionary technology platform by attending our presentation at Seed Showcase:
  ‍Tuesday, January 09, at 10:20AM in room Franciscan D.
  https://informaconnect.com/biotech-showcase/
• October 20, 2023 - NEH presents poster at 2023 AACC Preanalytical Phase Conference in Philadelphia, PA
  Link to poster
• October 6, 2023 - NEH attends Biofuture in NYC
  Thanks to all who attended our October 2023 presentation at Biofuture!
• June 12, 2023
  New England Hemolytics appoints Hayden Jeffreys as a Non-Executive Director
  Read more